Role of CRS Plus HIPEC in Gastric Cancer Peritoneal Carcinomatosis

被引：6
作者：
Graziosi, Luigina [1 ]
Marino, Elisabetta [1 ]
Donini, Annibale [1 ]
机构：
[1] Univ Perugia, Santa Maria della Misericordia Hosp, Dept Gen & Emergency Surg, I-06134 Perugia, Italy
来源：
JOURNAL OF SURGICAL ONCOLOGY | 2015年 / 111卷 / 02期
关键词：
SURGERY;
D O I：
10.1002/jso.23789
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：248 / 248
页数：1
相关论文
共 50 条
  • [41] Cytoreductive surgery and HIPEC in treatment of colorectal peritoneal carcinomatosis: experiment or standard care? A survey among oncologic surgeons and medical oncologists
    Hidde J. Braam
    Djamila Boerma
    Marinus J. Wiezer
    Bert van Ramshorst
    International Journal of Clinical Oncology, 2015, 20 : 928 - 934
  • [42] Impact of RAS, BRAF mutations and microsatellite status in peritoneal metastases from colorectal cancer treated with cytoreduction plus HIPEC: scoping review
    Zucchini, Valentina
    D'Acapito, Fabrizio
    Rapposelli, Ilario Giovanni
    Framarini, Massimo
    Di Pietrantonio, Daniela
    Turrini, Riccardo
    Pozzi, Eleonora
    Ercolani, Giorgio
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2025, 42 (01)
  • [43] Role of CT texture analysis for predicting peritoneal metastases in patients with gastric cancer
    Masci, Giorgio Maria
    Ciccarelli, Fabio
    Mattei, Fabrizio Ivo
    Grasso, Damiano
    Accarpio, Fabio
    Catalano, Carlo
    Laghi, Andrea
    Sammartino, Paolo
    Iafrate, Franco
    RADIOLOGIA MEDICA, 2022, 127 (03): : 251 - 258
  • [44] Prognosis of Colorectal Cancer With Peritoneal Carcinomatosis: Is a New Staging Necessary? Reply
    Franko, Jan
    Sargent, Daniel
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (18) : 2288 - 2289
  • [45] Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer
    Segelman, J.
    Akre, O.
    Gustafsson, U. O.
    Bottai, M.
    Martling, A.
    COLORECTAL DISEASE, 2014, 16 (05) : 359 - 367
  • [46] The Role of Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in Recurrent Ovarian Peritoneal Carcinomatosis
    Ozcan, Pirilti
    Duzgun, Ozgul
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (07):
  • [47] Influence of peritoneal carcinomatosis on perioperative outcome in palliative gastric bypass for malignant gastric outlet obstruction-a retrospective cohort study
    Bednarsch, Jan
    Czigany, Zoltan
    Heise, Daniel
    Zimmermann, Henning
    Boecker, Joerg
    Ulmer, Tom Florian
    Neumann, Ulf Peter
    Klink, Christian
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [48] Report CRS and HIPEC in a patient with recurrent ovarian cancer after PDS and adjuvant chemotherapy, a case report and MDT discussion
    Fotiou, Alexandros
    Psomiadou, Victoria
    Prodromidou, Anastasia
    Iavazzo, Christos
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2022, 43 (02) : 368 - 371
  • [49] Is There a Role for Intraperitoneal Chemotherapy, Including HIPEC, in the Management of Ovarian Cancer?
    Vergote, Ignace
    Harter, Philipp
    Chiva, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27) : 2420 - +
  • [50] Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology
    Blum Murphy, Mariela
    Ikoma, Naruhiko
    Wang, Xuemei
    Estrella, Jeannelyn
    Roy-Chowdhuri, Sinchita
    Das, Prajnan
    Minsky, Bruce D.
    Song, Shumei
    Mansfield, Paul
    Ajani, Jaffer
    Badgwell, Brian
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (08) : 2806 - 2811
12345